FOR IMMEDIATE RELEASE
Media Contact:
Katrina Norfleet
+1.240.221.2924
knorfleet@arvo.org
Posted: 5/5/2016

Pre-symptom Alzheimer’s disease detected with new eye scan

Seattle, Wash. – Early structural changes in the back of the eye — now visible with a newly developed eye scan — may indicate the onset of Alzheimer’s disease. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Seattle, Wash.

The new technique enabled scientists to detect the buildup of beta-amyloid (Ab) in the eye early in the disease’s progression, potentially widening the window for treatment.Alzheimer’s is a progressive disease that degrades memory and other functions. Ab are plaques found in the brain of Alzheimer’s patients and believed to be crucially involved in the disease.

Abstract Title: Nonvascular Retinal Imaging Markers of Preclinical Alzheimer’s Disease
Presentation Start/End Time: Thursday, May 5, 2016, 8:00am – 9:45am
Location: Exhibit/Poster Hall
Abstract Number: 5987 - D0078

# # #

The Association for Research in Vision and Ophthalmology (ARVO) is the largest eye and vision research organization in the world. Members include nearly 12,000 eye and vision researchers from over 75 countries. ARVO advances research worldwide into understanding the visual system and preventing, treating and curing its disorders. 

All abstracts accepted for presentation at the ARVO Annual Meeting represent previously unpublished data and conclusions. This research may be proprietary or may have been submitted for journal publication. Embargo policy: Journalists must seek approval from the presenter(s) before reporting data from paper or poster presentations. Press releases or stories on information presented at the ARVO Annual Meeting may not be released or published until the conclusion of the presentation.

Advertisement
Phoenix research labs